Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI
Objective: This study aims to investigate whether the high sensitive C-reactive protein (hsCRP) is associated with an ejection fraction of left ventricle (EFLV) in the early phase of ST-elevation myocardial infarction (STEMI), treated with the primary percutaneous intervention (pPCI), and to establi...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2020-06-01
|
| Series: | Erciyes Medical Journal |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=erciyesmedj&un=EMJ-86429 |
| _version_ | 1797914759075463168 |
|---|---|
| author | Edin Begic Slobodan Obradovic Slobodan Jankovic Radoslav Romanovic Nemanja Djenic Boris Dzudovic Zoran Jovic Dragana Malovic Vesna Subota Milena Stavric Farid Ljuca Zumreta Kusljugic |
| author_facet | Edin Begic Slobodan Obradovic Slobodan Jankovic Radoslav Romanovic Nemanja Djenic Boris Dzudovic Zoran Jovic Dragana Malovic Vesna Subota Milena Stavric Farid Ljuca Zumreta Kusljugic |
| author_sort | Edin Begic |
| collection | DOAJ |
| description | Objective: This study aims to investigate whether the high sensitive C-reactive protein (hsCRP) is associated with an ejection fraction of left ventricle (EFLV) in the early phase of ST-elevation myocardial infarction (STEMI), treated with the primary percutaneous intervention (pPCI), and to establish whether there exists a relationship between its values and the presence of major adverse cardiovascular events (MACE) within six months of pPCI.
Materials and Methods: In this prospective study, 357 patients who were diagnosed with STEMI and who underwent pPCI within 24 hours of pain onset were included. The following were monitored and recorded: 1) hsCRP values, which were measured between 24 and 48 hours of pPCI, 2) EFLV values, which were measured five days after the pPCI, and 3) MACE, which was established within six months of pPCI.
Results: The EFLV values measured five days after the pPCI were significantly lower with increasing hsCRP values (rho=-0.384, p<0.0001). There was a significant difference in hsCRP values between patients who had MACE and those without it (38.35 [98.10] vs. 12.97 [23.80], p=0.0001). In addition, hsCRP values were significantly increased in patients who died during the first six months after the pPCI compared with patients who survived (115.00 [202.80] vs. 15.84 [31.5], p=0.001).
Conclusion: The hsCRP values in patients with STEMI who were treated with the pPCI are related to systolic function in the early phase of STEMI, as well as MACE during the first six months of follow-up. |
| first_indexed | 2024-04-10T12:31:02Z |
| format | Article |
| id | doaj.art-a0ef86e83b8a4c4f87be5e646275e35b |
| institution | Directory Open Access Journal |
| issn | 2149-2247 |
| language | English |
| last_indexed | 2024-04-10T12:31:02Z |
| publishDate | 2020-06-01 |
| publisher | KARE Publishing |
| record_format | Article |
| series | Erciyes Medical Journal |
| spelling | doaj.art-a0ef86e83b8a4c4f87be5e646275e35b2023-02-15T16:14:54ZengKARE PublishingErciyes Medical Journal2149-22472020-06-0142327628010.14744/etd.2020.86429EMJ-86429Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMIEdin Begic0Slobodan Obradovic1Slobodan Jankovic2Radoslav Romanovic3Nemanja Djenic4Boris Dzudovic5Zoran Jovic6Dragana Malovic7Vesna Subota8Milena Stavric9Farid Ljuca10Zumreta Kusljugic11Department of Cardiology, General Hospital 'Prim.Dr. Abdulah Nakas', Sarajevo, Bosnia and Herzegovina; Department of Pharmacology, Sarajevo Medical School, Sarajevo School of Science and Technology, Sarajevo, Bosnia and HerzegovinaClinic for Emergency and Internal Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia; School of Medicine, University of Defence, Belgrade, SerbiaFaculty of Medical Sciences, University of Kragujevac, Kragujevac, SerbiaClinic for Emergency and Internal Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia; School of Medicine, University of Defence, Belgrade, SerbiaClinic for Emergency and Internal Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia; School of Medicine, University of Defence, Belgrade, SerbiaSchool of Medicine, University of Defence, Belgrade, Serbia; Institute of Biochemistry, Military Medical Academy, University of Defence, Belgrade, SerbiaClinic for Emergency and Internal Medicine, Military Medical Academy, University of Defence, Belgrade, Serbia; School of Medicine, University of Defence, Belgrade, SerbiaClinic for Emergency and Internal Medicine, Military Medical Academy, University of Defence, Belgrade, SerbiaSchool of Medicine, University of Defence, Belgrade, Serbia; Institute of Biochemistry, Military Medical Academy, University of Defence, Belgrade, SerbiaSchool of Medicine, University of Defence, Belgrade, Serbia; Institute of Biochemistry, Military Medical Academy, University of Defence, Belgrade, SerbiaDepartment of Physiology, Faculty of Medicine Tuzla, Tuzla, Bosnia and HerzegovinaDepartment for Science, Teaching and Clinical Trials, University Clinical Centre Tuzla, Tuzla, Bosnia and HerzegovinaObjective: This study aims to investigate whether the high sensitive C-reactive protein (hsCRP) is associated with an ejection fraction of left ventricle (EFLV) in the early phase of ST-elevation myocardial infarction (STEMI), treated with the primary percutaneous intervention (pPCI), and to establish whether there exists a relationship between its values and the presence of major adverse cardiovascular events (MACE) within six months of pPCI. Materials and Methods: In this prospective study, 357 patients who were diagnosed with STEMI and who underwent pPCI within 24 hours of pain onset were included. The following were monitored and recorded: 1) hsCRP values, which were measured between 24 and 48 hours of pPCI, 2) EFLV values, which were measured five days after the pPCI, and 3) MACE, which was established within six months of pPCI. Results: The EFLV values measured five days after the pPCI were significantly lower with increasing hsCRP values (rho=-0.384, p<0.0001). There was a significant difference in hsCRP values between patients who had MACE and those without it (38.35 [98.10] vs. 12.97 [23.80], p=0.0001). In addition, hsCRP values were significantly increased in patients who died during the first six months after the pPCI compared with patients who survived (115.00 [202.80] vs. 15.84 [31.5], p=0.001). Conclusion: The hsCRP values in patients with STEMI who were treated with the pPCI are related to systolic function in the early phase of STEMI, as well as MACE during the first six months of follow-up.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=erciyesmedj&un=EMJ-86429c-reactive proteinmyocardial infarctionprognosis |
| spellingShingle | Edin Begic Slobodan Obradovic Slobodan Jankovic Radoslav Romanovic Nemanja Djenic Boris Dzudovic Zoran Jovic Dragana Malovic Vesna Subota Milena Stavric Farid Ljuca Zumreta Kusljugic Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI Erciyes Medical Journal c-reactive protein myocardial infarction prognosis |
| title | Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI |
| title_full | Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI |
| title_fullStr | Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI |
| title_full_unstemmed | Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI |
| title_short | Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI |
| title_sort | increased high sensitive c reactive protein is associated with major adverse cardiovascular events after stemi |
| topic | c-reactive protein myocardial infarction prognosis |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=erciyesmedj&un=EMJ-86429 |
| work_keys_str_mv | AT edinbegic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT slobodanobradovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT slobodanjankovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT radoslavromanovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT nemanjadjenic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT borisdzudovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT zoranjovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT draganamalovic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT vesnasubota increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT milenastavric increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT faridljuca increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi AT zumretakusljugic increasedhighsensitivecreactiveproteinisassociatedwithmajoradversecardiovasculareventsafterstemi |